Risk factors for acute kidney injury in patients hospitalized with COVID-19
- PMID: 38078832
- PMCID: PMC11210541
- DOI: 10.1590/2175-8239-JBN-2023-0056en
Risk factors for acute kidney injury in patients hospitalized with COVID-19
Abstract
Introduction: Acute kidney injury (AKI) occurs frequently in COVID-19 patients and is associated with greater morbidity and mortality. Knowing the risks of AKI allows for identification, prevention, and timely treatment. This study aimed to identify the risk factors associated with AKI in hospitalized patients.
Methods: A descriptive, retrospective, cross-sectional, and analytical component study of adult patients hospitalized with COVID-19 from March 1 to December 31, 2020 was carried out. AKI was defined by the creatinine criteria of the KDIGO-AKI guidelines. Information, regarding risk factors, was obtained from electronic medical records.
Results: Out of the 934 patients, 42.93% developed AKI, 60.59% KDIGO-1, and 9.9% required renal replacement therapy. Patients with AKI had longer hospital stay, higher mortality, and required more intensive care unit (ICU) admission, mechanical ventilation, and vasopressor support. Multivariate analysis showed that age (OR 1.03; 95% CI 1.02-1.04), male sex (OR 2.13; 95% CI 1.49-3.04), diabetes mellitus (DM) (OR 1.55; 95% CI 1.04-2.32), chronic kidney disease (CKD) (OR 2.07; 95% CI 1.06-4.04), C-reactive protein (CRP) (OR 1.02; 95% CI 1.00-1.03), ICU admission (OR 1.81; 95% CI 1.04-3.16), and vasopressor support (OR 7.46; 95% CI 3.34-16.64) were risk factors for AKI, and that bicarbonate (OR 0.89; 95% CI 0.84-0.94) and partial pressure arterial oxygen/inspired oxygen fraction index (OR 0.99; 95% CI 0.98-0.99) could be protective factors.
Conclusions: A high frequency of AKI was documented in COVID-19 patients, with several predictors: age, male sex, DM, CKD, CRP, ICU admission, and vasopressor support. AKI occurred more frequently in patients with higher disease severity and was associated with higher mortality and worse outcomes.
Introdução:: Lesão renal aguda (LRA) ocorre frequentemente em pacientes com COVID-19 e associa-se a maior morbidade e mortalidade. Conhecer riscos da LRA permite a identificação, prevenção e tratamento oportuno. Este estudo teve como objetivo identificar fatores de risco associados à LRA em pacientes hospitalizados.
Métodos:: Realizou-se estudo descritivo, retrospectivo, transversal e de componente analítico de pacientes adultos hospitalizados com COVID-19 de 1º de março a 31 de dezembro, 2020. Definiu-se a LRA pelos critérios de creatinina das diretrizes KDIGO-LRA. Informações sobre fatores de risco foram obtidas de prontuários eletrônicos.
Resultados:: Dos 934 pacientes, 42,93% desenvolveram LRA, 60,59% KDIGO-1 e 9,9% necessitaram de terapia renal substitutiva. Pacientes com LRA apresentaram maior tempo de internação, maior mortalidade e necessitaram de mais internações em UTIs, ventilação mecânica e suporte vasopressor. A análise multivariada mostrou que idade (OR 1,03; IC 95% 1,02–1,04), sexo masculino (OR 2,13; IC 95% 1,49–3,04), diabetes mellitus (DM) (OR 1,55; IC 95% 1,04–2,32), doença renal crônica (DRC) (OR 2,07; IC 95% 1,06–4,04), proteína C reativa (PCR) (OR 1,02; IC 95% 1,00–1,03), admissão em UTI (OR 1,81; IC 95% 1,04–3,16) e suporte vasopressor (OR 7,46; IC 95% 3,34–16,64) foram fatores de risco para LRA, e que bicarbonato (OR 0,89; IC 95% 0,84–0,94) e índice de pressão parcial de oxigênio arterial/fração inspirada de oxigênio (OR 0,99; IC 95% 0,98–0,99) poderiam ser fatores de proteção.
Conclusões:: Documentou-se alta frequência de LRA em pacientes com COVID-19, com diversos preditores: idade, sexo masculino, DM, DRC, PCR, admissão em UTI e suporte vasopressor. LRA ocorreu mais frequentemente em pacientes com maior gravidade da doença e associou-se a maior mortalidade e piores desfechos.
Conflict of interest statement
The authors declare that they have no conflict of interest related to the publication of this manuscript.
Similar articles
-
Impact of hospital-acquired acute kidney injury on Covid-19 outcomes in patients with and without chronic kidney disease: a multicenter retrospective cohort study.Turk J Med Sci. 2021 Jun 28;51(3):947-961. doi: 10.3906/sag-2011-169. Turk J Med Sci. 2021. PMID: 33611868 Free PMC article.
-
Acute kidney injury associated with COVID-19: A retrospective cohort study.PLoS Med. 2020 Oct 30;17(10):e1003406. doi: 10.1371/journal.pmed.1003406. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33125416 Free PMC article.
-
Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.BMC Nephrol. 2021 Mar 15;22(1):92. doi: 10.1186/s12882-021-02296-z. BMC Nephrol. 2021. PMID: 33722189 Free PMC article.
-
Kidney disease and COVID-19 disease severity-systematic review and meta-analysis.Clin Exp Med. 2022 Feb;22(1):125-135. doi: 10.1007/s10238-021-00715-x. Epub 2021 Apr 23. Clin Exp Med. 2022. PMID: 33891214 Free PMC article.
-
Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysis.Crit Care. 2020 Jan 2;24(1):2. doi: 10.1186/s13054-019-2710-4. Crit Care. 2020. PMID: 31898523 Free PMC article.
Cited by
-
Acute Kidney Injury in the Context of COVID-19: An Analysis in Hospitalized Mexican Patients.Infect Dis Rep. 2024 May 16;16(3):458-471. doi: 10.3390/idr16030034. Infect Dis Rep. 2024. PMID: 38804444 Free PMC article.
-
Editorial: Global excellence in renal pharmacology 2022: Central and South America.Front Pharmacol. 2024 Jan 9;14:1362010. doi: 10.3389/fphar.2023.1362010. eCollection 2023. Front Pharmacol. 2024. PMID: 38269280 Free PMC article. No abstract available.
-
Acute kidney injury in critically ill COVID-19 patients in a tertiary hospital: short and long-term kidney and patient outcomes.J Bras Nefrol. 2025 Jan-Mar;47(1):e20240107. doi: 10.1590/2175-8239-JBN-2024-0107en. J Bras Nefrol. 2025. PMID: 39792860 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous